Description: Ceftorque T 1.125 Dry Injection is a medication combining Ceftriaxone and Tazobactam is used in the treatment of the bacterial infection. Pharmaceutical Dosage Form: Dry Injection Route of Administration: Injection Composition: Each Vail contains: Ceftriaxone Sodium (Sterile) Eq. to Anhydrous Ceftriaxone I.P. 1000 mg Tazobactum Sodium (Sterile) Eq. to Anhydrous Tazobactum I.P. 125 mg Mechanism of Action: Ceftriaxone belongs to the class of antibiotics that works by interfering with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damaging the bacterial cell wall and killing bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance. Indications: Ceftorque T 1.125 is used to treat Respiratory Tract infection, Intra-Abdominal Infection, Urinary Tract Infection, Septicemia, Meningitis. Dosage: As prescribed by the physician. Storage: Store protected from light and moisture at a temperature not exceeding 250 Presentation: 12 x 20 x 10ml Side effects: Nausea Headache Dizziness Abdominal pain Diarrhea Contraindications: Ceftorque T 1.125 is contraindicated in patients with a history of hypersensitivity to the beta-lactum antibiotics.